Patients News | pharmaphorum

News

Nerve damage-tracking pen to be used in CAR-T patients

Nerve damage is a recognised side effect of some CAR-T therapies for cancer, and one that could be spotted early using a pen device developed by UK company Manus Neurodyna

News

Supreme Court presses pause on mifepristone curbs

The US Supreme Court has said it will allow the abortion pill mifepristone to remain available while an appeal of the decision to strike down its regulatory approval make

News

US senators unveil their PBM reform plan

Senior lawmakers in the US across both sides of the political divide have released a list of measures that they are considering to reduce medicine costs for patients and t

News

Inquest says doctor died of COVID-19 jab complication

An inquest in the UK has concluded that the death of a UK doctor in January 2021 shortly after being immunised against COVID-19 was a “rare and unintended complication” of

News

Call for ‘more trial, less error’ in study diversity

A report from a UK think tank focused on the impact of longevity on society has found that people aged over 60 are still poorly represented in clinical trials – even thoug

News

Biomarker hailed as “game changer” in Parkinson’s

Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated.

Nerve damage-tracking pen to be used in CAR-T patients

Supreme Court presses pause on mifepristone curbs

US senators unveil their PBM reform plan

Inquest says doctor died of COVID-19 jab complication

Call for ‘more trial, less error’ in study diversity

Biomarker hailed as “game changer” in Parkinson’s

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks